Status:
COMPLETED
Accelerated Brain Volume Loss in People With Multiple Sclerosis
Lead Sponsor:
National MS Center Melsbroek
Conditions:
Retrospective Study
Eligibility:
All Genders
18-65 years
Brief Summary
To explore whether brain volume loss (BVL) in people with multiple sclerosis (MS), assessed on magnetic imaging (MRI) data obtained during routine medical follow-up (and thus outside a standardized re...
Detailed Description
This project will not be the first study on real-world data in an existing MS cohort. A NMSC research group has already reported on the contribution of a single brain volumetric assessment to the pred...
Eligibility Criteria
Inclusion
- MRI and volumetry performed minimum 48 and maximum 60 months apart
Exclusion
- none
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05408767
Start Date
January 1 2021
End Date
May 1 2022
Last Update
June 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationaal Multiple Sclerose Centrum Melsbroek
Melsbroek, Vlaams-Brabant, Belgium, 1820